Cptx
1 known investors
Captain T (cptx.bio) is a genetic medicines company developing in vivo CAR-T therapies built on an immune-silent single-stranded DNA (ssDNA) platform, aiming to overcome the limitations of viral vectors and mRNA. Its therapies target patients as an alternative to traditional cell therapy approaches.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Cptx do?
- Captain T (cptx.bio) is a genetic medicines company developing in vivo CAR-T therapies built on an immune-silent single-stranded DNA (ssDNA) platform, aiming to overcome the limitations of viral vectors and mRNA. Its therapies target patients as an alternative to traditional cell therapy approaches.
- Who are Cptx's investors?
- Cptx's investors include BlueYard Capital.